Discovering New Challenges in the Pharmacological and Non-Pharmacological Management of Insulin Resistance
Open Access
- 1 September 2026
- journal article
- Published by Bentham Science Publishers Ltd. in Current Diabetes Reviews
- Vol. 22 (7)
Abstract
Introduction: Insulin resistance has become a serious health problem over time. As people age, the incidence of insulin resistance increases. Genetic factors in families with a history of type 2 diabetes are also key risk factors. In Indonesia, an increase in the prevalence of type 2 diabetes to 8.5% was reported in 2018. This indicates that insulin resistance necessitates comprehensive management, encompassing both pharmacological and non-pharmacological approaches. This systematic review aims to discuss insulin resistance and its management, which can be achieved both pharmacologically through various available drugs and non-pharmacologically by modifying lifestyle habits that can be applied to patients with type 2 diabetes. Method: Studies examining the comprehensive management of insulin resistance with antidiabetic pharmacological drugs and non-pharmaceutical interventions published between 2018 and 2023 were comprehensively searched using advanced searches on PubMed and Google Scholar, according to the specified inclusion and exclusion criteria. Results: Twenty studies were selected that met the inclusion criteria and have low risks of bias in most domains. Discussion: Non-pharmacological therapy, such as lifestyle changes that include a ketogenic diet, a vegetarian diet, a structured exercise intervention program, aerobic exercise, Continuous Positive Airway Pressure (CPAP), and electroacupuncture therapy, can significantly reduce insulin resistance and increase insulin sensitivity. Drugs currently prescribed for type 2 DM stimulate insulin secretion or increase insulin sensitivity. Conclusion: There are benefits of a plant-based diet, a ketogenic diet, and physical exercise in reducing insulin resistance non-pharmacologically. Meanwhile, pharmacologically, the first drug often given is metformin monotherapy. Combination therapy may be considered if monotherapy does not achieve the therapeutic target.Keywords
This publication has 85 references indexed in Scilit:
- Early onset type 2 diabetes mellitus: an updateEndocrine, 2024
- Effects of a vegetarian diet combined with aerobic exercise on glycemic control, insulin resistance, and body composition: a systematic review and meta-analysisEating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 2023
- Embracing complexity: making sense of diet, nutrition, obesity and type 2 diabetesDiabetologia, 2023
- Diabetes mellitus – Definition, Klassifikation, Diagnose, Screening und Prävention (Update 2023)Wiener klinische Wochenschrift, 2023
- Oxidative Stress: Pathogenetic Role in Diabetes Mellitus and Its Complications and Therapeutic Approaches to CorrectionBulletin of Experimental Biology and Medicine, 2021
- The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular RiskCurrent Diabetes Reports, 2021
- Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and ObesityJAMA Network Open, 2021
- An atlas on risk factors for type 2 diabetes: a wide-angled Mendelian randomisation studyDiabetologia, 2020
- Improving type 2 diabetes mellitus glycaemic control through lifestyle modification implementing diet intervention: a systematic review and meta-analysisEuropean Journal of Nutrition, 2019
- Genetics of Insulin Resistance and the Metabolic SyndromeCurrent Cardiology Reports, 2016